Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Go back to Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.99 +0.07 (2.40%)
Previous Close $2.92    52 Week High $4.76 
Open $2.93    52 Week Low $1.46 
Day High $3.12    P/E N/A 
Day Low $2.84    EPS $-1.91 
Volume 3,394,527